Development and evaluation of an intervention to support Adherence to treatment in adults with cystic fibrosis: A feasibility study comprised of an external pilot randomised controlled trial and process evaluation (WP 3.1)

Overview

Phase: N/A
Intervention: Not specified
Conditions: Specialty: Respiratory disorders, Primary sub-specialty: Respiratory disorders
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Enrollment: 61
Status: Completed
Last Updated: 2 years ago

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29886416 results (added 08/05/2019) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32697197/ results (added 24/07/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34665573/ (added 10/07/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33109661/ (added 10/07/2023) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30975206/ (added 10/07/2023)

Registry

who.int

Start Date

June 7, 2016

End Date

April 30, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\. Diagnosed with CF and within CF registry
•2\. Aged 16 years and above
•3\. Taking inhaled mucolytics or antibiotics via a chipped nebuliser (e.g. eTrack or I\-Neb or able and willing to take via eTrack or I\-Neb)

•1\. Post\-lung transplant
•2\. People on the active lung transplant list
•3\. Patients receiving palliative care, with palliative intent, for whom trial participation could be a burden
•4\. Participants who lack capacity to give informed consent 5\) Participants using dry powder devices to take antibiotics or mucolytics